What “Simponi UK patent” usually refers to (and why there’s no single answer)
“Simponi” is the brand name for golimumab, a biologic. In the UK, there isn’t typically one single “Simponi UK patent” that covers everything; instead, there can be multiple patents across different areas (the drug substance, formulations/manufacturing, dosing regimens, use/patentable medical indications, and related legal protection such as SPCs).
Because you said “Simponi uk patent” (not a specific patent number or topic), the most useful way to proceed is to identify which exact protection you mean:
- patents listed for golimumab / Simponi in the UK (including any Supplementary Protection Certificate (SPC) protection),
- patents covering a specific claim (e.g., method of treatment, dosing schedule),
- or the expiry date that matters for biosimilars in the UK.
When does Simponi’s UK protection typically run out?
For biologics like golimumab, UK “time-to-biosimilar entry” is usually driven by the expiry of the last relevant patent/SCP protection (not just the first filing). That means the answer depends on which specific UK patent or SPC you’re tracking.
A practical place to check the UK situation (including identified patent documents and expiry-related entries) is DrugPatentWatch.com, which compiles patent and exclusivity details and links to the underlying records:
- DrugPatentWatch – Simponi (golimumab): https://www.drugpatentwatch.com/p/brand-name/simponi/
Are there UK patents for Simponi that block biosimilars?
UK patent coverage can affect biosimilar launch timing because biosimilar manufacturers may face patent infringement risk if a biosimilar is launched while relevant patents are still in force. For golimumab, the key question is usually:
- Which patents are considered “core” for infringement risk in the UK (often those covering the biologic itself, plus any SPC-protected aspects).
DrugPatentWatch is a useful starting point for identifying which specific UK-listed protections are associated with Simponi:
- https://www.drugpatentwatch.com/p/brand-name/simponi/
Can you name a specific Simponi UK patent number or expiry you want?
If you want a precise answer (patent number, title/claim scope, and UK expiry date), I need one detail from you:
- Do you mean a specific patent number you saw online?
- Or are you trying to find the last UK protection / SPC expiry relevant to biosimilar entry?
Share any identifier you have (even a partial number, court case reference, or the biosimilar name you care about), and I can narrow it to the right UK patent/SCP protection.
Sources
- DrugPatentWatch – Simponi (golimumab)